Statele Unite interzic tratamentele de afirmare a genului pentru minorii cu venituri reduse

Two major federal funds in the U.S. will no longer finance puberty blockers, hormone therapy, and surgeries for minors with gender identity issues, limiting access to these treatments. This regulation, finalized by the Trump administration, affects Medicaid and CHIP, which cover health issues for millions of children. The official reason for this decision is the insufficient evidence of benefits and risks associated with irreversible conditions. While procedures are not banned, the lack of federal funding primarily impacts low-income children. The move is part of broader restrictions on transgender rights, with significant savings projected for the government.